[go: up one dir, main page]

MX2012003001A - Proceso para la produccion de intermediarios de artemisina. - Google Patents

Proceso para la produccion de intermediarios de artemisina.

Info

Publication number
MX2012003001A
MX2012003001A MX2012003001A MX2012003001A MX2012003001A MX 2012003001 A MX2012003001 A MX 2012003001A MX 2012003001 A MX2012003001 A MX 2012003001A MX 2012003001 A MX2012003001 A MX 2012003001A MX 2012003001 A MX2012003001 A MX 2012003001A
Authority
MX
Mexico
Prior art keywords
production
artemisine
intermediaries
acid esters
artemisinic
Prior art date
Application number
MX2012003001A
Other languages
English (en)
Inventor
Volker Kraft
Gerhard Kretzschmar
Kai Rossen
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of MX2012003001A publication Critical patent/MX2012003001A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/36Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by hydrogenation of carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/26Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/303Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by hydrogenation of unsaturated carbon-to-carbon bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/608Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a ring other than a six-membered aromatic ring in the acid moiety
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/26All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/28Hydrogenated naphthalenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta solicitud se refiere a un proceso para la producción de ácido (2R)-dihidroartemisínico o ésteres de ácido (2R)-dihidroartemisínico a partir de ácido artemisínico o ésteres de ácido artemisínico, respectivamente, mediante la hidrogenación de diimina del doble enlace CC exocíclico, y uso del proceso en la producción de la artemisinina para fármaco antimalaria.
MX2012003001A 2009-09-11 2010-09-10 Proceso para la produccion de intermediarios de artemisina. MX2012003001A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24174409P 2009-09-11 2009-09-11
PCT/IB2010/002566 WO2011030223A2 (en) 2009-09-11 2010-09-10 Process for the production of artemisinin intermediates

Publications (1)

Publication Number Publication Date
MX2012003001A true MX2012003001A (es) 2012-07-17

Family

ID=43567786

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012003001A MX2012003001A (es) 2009-09-11 2010-09-10 Proceso para la produccion de intermediarios de artemisina.

Country Status (21)

Country Link
US (1) US8334392B2 (es)
EP (1) EP2475635B1 (es)
JP (1) JP5711745B2 (es)
KR (1) KR20120065395A (es)
CN (1) CN102612507B (es)
AU (2) AU2010293907B2 (es)
BR (1) BR112012005345A2 (es)
CA (1) CA2773007C (es)
DK (1) DK2475635T3 (es)
EA (1) EA021061B1 (es)
ES (1) ES2634940T3 (es)
HR (1) HRP20171139T1 (es)
HU (1) HUE035319T2 (es)
IL (2) IL218483A (es)
LT (1) LT2475635T (es)
MX (1) MX2012003001A (es)
MY (1) MY155952A (es)
PT (1) PT2475635T (es)
SI (1) SI2475635T1 (es)
SM (1) SMT201700342T1 (es)
WO (1) WO2011030223A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2751113B1 (en) * 2011-08-29 2017-07-05 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method and device for the synthesis of artemisinin
EP2565197A1 (en) 2011-08-29 2013-03-06 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method and device for the synthesis of artemisinin
EP2660234A1 (en) 2012-05-02 2013-11-06 Sanofi Process for the production of artemisinin intermediates
CN103087074A (zh) * 2012-12-14 2013-05-08 湖南科源生物制品有限公司 一种青蒿素的半合成方法
CN103755550B (zh) * 2013-11-28 2016-03-02 湖南科源生物制品有限公司 一种二氢青蒿酸的合成方法
CN112538010B (zh) * 2019-09-20 2023-08-11 凯特立斯(深圳)科技有限公司 一种青蒿素类化合物合成关键中间体的制备方法
DE102020120218A1 (de) 2020-07-31 2022-02-03 KBHB Consult GmbH Gegen das ribosomale Protein rpL35/uL29 gerichtete Moleküle zur Verwendung in der Behandlung von Erkrankungen, insbesondere Epidermolysis bullosa (EB)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992561A (en) * 1990-05-11 1991-02-12 The United States Of America As Represented By The Secretary Of The Army Simple conversion of artemisinic acid into artemisinin
IN184682B (es) 1995-12-29 2000-09-23 Council Scient Ind Res
JP3148136B2 (ja) * 1996-12-26 2001-03-19 高砂香料工業株式会社 新規なキラルジホスフィン化合物、その製造中間体、該ジホス フィン化合物を配位子とする遷移金属錯体並びに該錯体を含む 不斉水素化触媒
US5995084A (en) * 1997-01-17 1999-11-30 Tritech Microelectronics, Ltd. Touchpad pen-input and mouse controller
IN188174B (es) 1997-03-17 2002-08-31 Council Scient Ind Res
JP3549390B2 (ja) * 1998-03-23 2004-08-04 高砂香料工業株式会社 ルテニウム−ホスフィン錯体及びその製造方法
US20060270863A1 (en) * 2005-05-27 2006-11-30 Amyris Biotechnologies Conversion of amorpha-4,11-diene to artemisinin and artemisinin precursors
CN1900081A (zh) * 2005-07-22 2007-01-24 中国科学院上海药物研究所 水溶性青蒿素衍生物、制法、药物组合物及用途
WO2009088404A1 (en) * 2007-12-30 2009-07-16 Amyris Biotechnologies, Inc. Processes for the preparation of artemisinin an its precursors

Also Published As

Publication number Publication date
BR112012005345A2 (pt) 2016-03-22
JP5711745B2 (ja) 2015-05-07
AU2010293907A1 (en) 2012-04-26
DK2475635T3 (en) 2017-07-03
IL218483A (en) 2016-07-31
US20110230669A1 (en) 2011-09-22
AU2010293907B2 (en) 2016-03-03
WO2011030223A2 (en) 2011-03-17
HRP20171139T1 (hr) 2017-10-06
MY155952A (en) 2015-12-31
PT2475635T (pt) 2017-07-10
CN102612507A (zh) 2012-07-25
IL218483A0 (en) 2012-04-30
EP2475635A2 (en) 2012-07-18
CA2773007C (en) 2017-04-25
LT2475635T (lt) 2017-07-25
CA2773007A1 (en) 2011-03-17
HUE035319T2 (en) 2018-05-02
JP2013504557A (ja) 2013-02-07
ES2634940T3 (es) 2017-09-29
SMT201700342T1 (it) 2017-09-07
KR20120065395A (ko) 2012-06-20
SI2475635T1 (sl) 2017-08-31
WO2011030223A3 (en) 2011-05-19
AU2016203676A1 (en) 2016-06-16
CN102612507B (zh) 2015-04-22
EA021061B1 (ru) 2015-03-31
EP2475635B1 (en) 2017-04-26
EA201270409A1 (ru) 2012-12-28
US8334392B2 (en) 2012-12-18
IL246336A0 (en) 2016-08-31

Similar Documents

Publication Publication Date Title
CR20120464A (es) Anticuerpos bivalentes biespecíficos anti-vefg/anti-ang-2
MX2012003001A (es) Proceso para la produccion de intermediarios de artemisina.
CR20110466A (es) Anticuerpos biespecíficos anti-erbb-3/anti-c-met
DOP2017000013A (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
MX353706B (es) Anticuerpos contra csf-1r humano y usos de los mismos.
UY33776A (es) Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso
CO6440531A2 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
GT201400085A (es) Profármaco de adrenomedulina basado en polietilenglicol y su uso
CL2014002794A1 (es) Procedimiento para reducir la produccion de metano en rumiantes que comprende administrar una composicion de pienso que contiene glucosido de flavanona seleccionado del grupo constituido por neohesperidina, isonaringina, poncirina y hesperidina o mezcla de los mismos.
DOP2014000255A (es) Uracilos sustituidos bicíclicamente y uso de los mismos
DOP2007000043A (es) Derivados de cromanol sustituidos y su uso
UA86731C2 (ru) Делимая галеновая форма модифицированного высвобождения активного ингредиента
WO2011009938A3 (en) Stambomycin and derivatives, their production and their use as drugs
WO2013080217A3 (en) Crystalline forms of carbazitaxel and process for preparation thereof
MX2015001051A (es) Derivados de manosa, un proceso para su preparacion y sus usos como un farmaco.
CR20120082A (es) Conservantes de derivados de quitina
ECSP11011483A (es) Piperidinas sustituidas
EP2889287A4 (en) DOLASTATIN-10-DERIVAT, PROCESS FOR THE PREPARATION THEREOF AND ANTI-CANCER MEDICAMENT THEREWITH
EA201400444A1 (ru) Производные 2-оксопиперидинила
CU20110214A7 (es) Piperidinas sustituidas
UY31903A (es) 7-sulfanilmetil-,7-silfinilmetil-y7-sulfonilmetilindoles sustituidos y el uso de los mismos
CL2015000015A1 (es) Microorganismos modificados genéticamente capaces de producir beta-glucanos y métodos para la producción de beta-glucanos.
CU20080122A7 (es) Nuevos derivados de furopirimidina acíclicos sustituidos y su uso
BR112013029148A2 (pt) composição, processo de produção de uma composição, uso da composição e método para fornecer conforto digestivo

Legal Events

Date Code Title Description
FG Grant or registration